Back

Timing and technique matter: closure of secundum atrial septal defect and risk of incident and recurrent arrhythmia

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Adult congenital heart disease: interventional treatment Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Eva Havers-Borgersen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Long-term follow-up outcomes after percutaneous balloon pulmonary valvuloplasty in 357 children with pulmonary stenosis
Professor B. Han (Jinan, CN)
Abstract Slides Video
Presentation thumbnail
Impact of percutaneous atrial septal defect closure device size and design on left atrial function
Doctor G. Hashimoto (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Age-related changes in GORE TEX Vascular Graft during conduit puncture after Fontan surgery (mechanical, imaging and pathological assessment)
Doctor H. Aoki (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Long-term outcome after surgical ventricular septal defect closure at young age: longitudinal follow-up into the fifth decade after surgery.
Miss S. Unluturk (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Trigger criteria for advance care planning in adults with congenital heart disease: a systematic review
Doctor M. Possner (Bern, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Adult congenital heart disease: interventional treatment

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Altered cardiac dimensions in preschool children with and without spontaneous closure of neonatal atrial septal defects
thumbnail
Congress Session
Personalised care for atrial septal defect
thumbnail
Congress Presentation
Long-term outcome after surgical ventricular septal defect closure at young age: longitudinal follow-up into the fifth decade after surgery.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources